ClinicalTrials.gg
Active, not recruitingNCT04833829CHIMESUpdated Nov 14, 2025

Cross-disciplinary HIV Integrated Mental Health Support Intervention

An interventional study of CHIMES Intervention and Standard of Care in Human Immunodeficiency Virus and HIV Infections, sponsored by Emory University. Active, not recruiting at 2 sites in United States. Open to male participants aged 18 Years to 29 Years. Per ClinicalTrials.gov, last updated 2025-11-14.

Primary conditionHIV InfectionsRegistry: Acquired Immunodeficiency SyndromeReclassifiedWhy we changed it
Registry
Acquired Immunodeficiency Syndrome — the first condition term the registry derived for this study.
ClinicalTrials.gg
HIV Infections
Why
  1. The registry often attaches Acquired Immunodeficiency Syndrome to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name HIV Infections.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Emory University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Nov 2020, registered Apr 2021).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
850
Allocation
Non-randomized
Ages
18 Years to 29 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 19 studies in HIV Infections by Emory University — 4 open to participants now, 6 under way, none of them phase 3. HIV Infections · Emory University.

Planned enrollment
2nd of 17
850 · median 63
Started
2020
with 1 other
No phase
9 of 19
3 open now
Registered
14th of 19
by date

Among the 19 studies in HIV Infections by Emory University, this one is the 2nd largest by planned enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2020, is one of 9 with no phase, and was the 14th registered.

HIV Infections

4,737 studies on the registry are indexed under HIV Infections; 247 are open to participants now.

Browse HIV Infections studies →

Open to participants now

4 of the 19 studies in HIV Infections by Emory University are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Who these studies take

Of the 159 HIV Infections studies recruiting now, 104 (65%) set no upper age limit and 42 (26%) stop at 75 or younger; 31 take children under 18; 60 take healthy volunteers.

This study: 18 Years to 29 Years · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in HIV Infections by Emory University, or all of them as a file.
02

Study summary

The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.

Read the detailed description

Young Black gay, bisexual and other men who have sex with men (YB-GBMSM) are disproportionately impacted by HIV, with suboptimal rates of engagement across the HIV Continuum of Care (HIV-CoC). Mental health (MH) comorbidities contribute to poor HIV care engagement for many YB-GBMSM; however, effective treatment for these conditions is hindered by barriers including logistical challenges, medical mistrust, and MH stigma.

The Ryan White Care act supports integration of HIV and MH services; however, preliminary studies demonstrate low rates of MH referrals and MH care engagement among YB-GBMSM living with HIV, even in these ostensibly integrated care settings. The objective of this study is to develop and implement CHIMES (Cross-disciplinary HIV Integrated with Mental Health Support), a clinic- and provider-level intervention to improve HIV-MH care integration and MH care engagement among YB-GBMSM attending Ryan White clinics.

The rationale for this study is that efforts to improve integration of services, particularly if they are culturally tailored, are likely to increase MH and HIV care engagement for YB-GBMSM. The proposed study will pursue two specific aims: (1) to develop the CHIMES intervention; and (2) to conduct a hybrid type 2 implementation-effectiveness pilot trial of CHIMES in two Health Resources and Services Administration (HRSA)/Ryan White-funded clinics in Atlanta, Georgia - a city in the heart of the Southern HIV epidemic.

For the first aim, the researchers will work collaboratively with provider and patient stakeholders, adapt existing evidence-based interventions, and build on formative data to refine intervention content, informed by the Capability- Opportunity-Motivation-Behavior (COM-B) Model. For the second aim, the researchers will implement CHIMES in the two clinic settings and conduct a mixed-methods assessment in which continuous data collection informed by the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework will be used to evaluate effectiveness and implementation processes.

The effectiveness of the CHIMES intervention will be measured by change in HIV and MH care engagement before, during, and after CHIMES implementation. The researchers will abstract clinic-level aggregate data to characterize change in HIV-CoC and MH care engagement outcomes for YB-GBMSM.

03

Conditions studied

  • Human Immunodeficiency Virus
  • HIV Infections

Browse trials for

Keywords

  • Mental health
04

In context

HIV Infections Reclassified

4,737 studies on the registry are indexed under HIV Infections; 247 are open to participants now.

This study's planned enrollment of 850 is above the median of 80 across 3,492 interventional studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

Emory University is the lead sponsor of 1,406 studies on the registry; 224 are open to participants now.

Of its 238 completed or terminated interventional studies of FDA-regulated products, 179 (75%) have results posted.

Compared within HIV Infections, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Acquired Immunodeficiency Syndrome. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • young Black gay, bisexual and other men who have sex with men (YB-GBMSM) living with
  • patient at Grady Health System Infectious Disease Program or Emory University Hospital Midtown Infectious Disease Clinic

Exclusion criteria

Exclusion Criteria:

  • none
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
850 participants (estimated)

Study arms

  • Active comparator
    Clinic Patients During the Pre-implementation Period

    Patients visiting one of the study clinics prior to implementation of the CHIMES intervention. The Baseline time period consists of study Months 1 - 12. Data are retroactively abstracted from medical records of patients who had clinic visits that occurred between January 1, 2019 and December 31, 2019.

    Behavioral: Standard of Care

  • Experimental
    Clinic Patients During the Implementation Period

    Patients visiting one of the study clinics during the Implementation period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 13 - 27.

    Behavioral: CHIMES Intervention

  • Experimental
    Clinic Patients During the Maintenance Period

    Patients visiting one of the study clinics during the Maintenance period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 28 - 33.

    Behavioral: CHIMES Intervention

Interventions

  • BehavioralCHIMES Intervention

    There are six components to the intervention: 1. Posters and other print materials to prompt providers and patients to discuss MH care engagement. 2. Brief verbal scripts to help HIV providers facilitate patient MH engagement and discuss barriers to MH utilization. 3. Expanded MH screening procedures, including at initial intake. 4. Case management, emphasizing MH care engagement. 5. Interactive trainings for all HIV providers on MH needs, screening/treatment, and barriers to MH service utilization specific to YB-GBMSM. 6. Regular case review meetings.

  • BehavioralStandard of Care

    The standard of care practices of referring patients to mental health services of the clinic during Months 1 - 12 of the study.

07

What researchers measure

Primary outcomes

  1. Number of Mental Health Visits

    The number of mental health visits by clinic patients during each study time period.

    Time frame: Baseline (Months 1-12) up to Month 33

  2. Percentage of Mental Health Visits by YB-GBMSM

    The percentage of mental health visits by YB-GBMSM clinic patients during each study time period.

    Time frame: Baseline (Months 1-12) up to Month 33

  3. Number of Patients Attending Two HIV Care Visits

    The number of patients who come to two HIV Care visits in a 12 month period, during each study time period.

    Time frame: Baseline (Months 1-12) up to Month 33

  4. Number of Patients with HIV RNA Viral Suppression

    The number of patients with HIV RNA less than 200 Copies, during each study time period.

    Time frame: Baseline (Months 1-12) up to Month 33

  5. Number of Mental Health Care Referrals

    The number of referrals to mental health care during a 12 month period, during each study time period.

    Time frame: Baseline (Months 1-12) up to Month 33

  6. Percentage of Mental Health Referrals for YB-GBMSM

    The percentage of mental health referrals by YB-GBMSM clinic patients during each study time period.

    Time frame: Baseline (Months 1-12) up to Month 33

08

Study locations

2 sites
  • Grady Infectious Diseases Clinic (Ponce Clinic)
    Atlanta, Georgia 30308, United States
  • Emory Midtown Hospital Infectious Disease Outpatient Clinic
    Atlanta, Georgia 30322, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — De-identified participant data will be made available to other researchers, using established public repositories.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Participant data will be made available for sharing after publication of this study.

Access criteria: Data will be available to other researchers using established public repositories.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2020 (actual). Primary completion is estimated for Nov 2026, 72 months after the start.

Of 393 non-industry interventional studies with no phase under HIV Infections, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 45. This study's planned 72 months is above that.

Counting every sponsor, half of 402 studies reached it within 28 months; a quarter within 16 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2021
First posted
Apr 6, 2021
StartActual
Nov 1, 2020
Primary completionEst.
Nov 2026
CompletionEst.
Nov 2026
Last update
Nov 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04833829
Lead sponsor
Emory University
Responsible party
Sophia Hussen (Associate Professor, Emory University) — Principal investigator
First posted
Apr 6, 2021
Start date
Nov 1, 2020
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Nov 14, 2025

Study contacts

Sophia Hussen, MD, MPH
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion